Dr Reddy’s Laboratories Ltd today said its consolidated profit after tax for the quarter ended March 31 jumped over three-fold to Rs 312.5 crore (as per IFRS) as against Rs 74.6 crore in the same quarter last year. As per Indian accounting standards (Ind AS), consolidated net profit was at Rs 337.6 crore and total income of the company stood at Rs 3,632.4 crore for the fourth quarter ended March 31. For the full year FY 2017, the drug maker’s net profit declined by 40% to Rs 1,204 crore against Rs 2,001 crore in FY16. Global Generic sales during the Q4 of FY 17 was down by 5% to Rs 2914 crore against Rs 3,077 crore in the corresponding period of last year. Revenues for fourth quarter was at Rs 1,530 crore.

Source: Hindustan Times May 13, 2017 14:37 UTC